English
Español
Français
Português
Русский
简体中文
Dr. Michael H. Gold is the founder and medical director of Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser & Rejuvenation Center, and Tennessee Clinical Research Center in Nashville, TN. He is a board-certified dermatologist and dermatologic surgeon and oversees the various facets of the center's operations — a combination of medical and surgical dermatology, cosmetic dermatology, aesthetic services and research endeavors, which began in 1990.
Dr. Gold has earned worldwide recognition for providing patients with leading-edge technological advances in dermatology and aesthetic skin care. He plays an integral role in the development of new pharmaceutical products and medical devices through his clinical research. He presents the results regularly at national and international dermatology and cosmetic meetings.
Dr. Gold has authored over 400 published scientific articles, 35 textbook chapters, and has edited two textbooks on Photodynamic Therapy. He serves on most major dermatology journal boards and is the current Editor-in-Chief of the Journal of Cosmetic Dermatology and Dermatological Reviews. Dr. Gold helped establish an annual meeting known as SCALE, or Symposium for Cosmetic Advances & Laser Education. It is one of the leading U.S. dermatologic and aesthetic meetings.
Dr. Gold also helped start two international groups: the Dermatologic Aesthetic Surgery International League (DASIL), which aims to create a global community for the open exchange of knowledge and innovation by physicians specializing in Dermatologic and Aesthetic Surgery. It has become one of the most prominent international dermatology groups. It showcases meetings all over the world; and 5-Continent-Congress (5CC), is one of the world’s leading conferences on Dermatologic and Aesthetic Surgery, where he is the current President of the Congress.
Energy-based technologies: The future of skin rejuvenation - (in collaboration with 5CC and DASIL)
ChairEnergy-based technologies: The future of skin rejuvenation - (in collaboration with 5CC and DASIL)
IPL Technology – What We Know From Research from Long-Term AnalysesCosmeceuticals: Nutrition & nutraceuticals for skin aging - Balancing risks and benefits!
ChairEXOCOBIO Symposium - Exosome Industry Creator with 53+ Scientific Publications : Exosome Therapy Cases from Resistance to Significant Response
What Makes ASCE Different?EXOCOBIO Symposium - Exosome Industry Creator with 53+ Scientific Publications : Exosome Therapy Cases from Resistance to Significant Response
Q&ALa Tribune - The Economic Forum - (Part 2)
ModeratorBoNTA: The revolution that lasts - (in collaboration with PSAD)
New Toxins in the US – What is Making its Way Through the Clinical Trial Domain in 2026Peels, mesotherapy and needling - Contributed talks
Microneedling RF in 2026 – What Have We Learned- LIVE DEMO - Upper face
Chair- BODY SHAPING - Breakthroughs from IMCAS World Congress
Body Contouring and Fat Reduction Treatments in 2026 – What is New and What Works With EBDs and Injectables- TOXINS - Breakthroughs from IMCAS World Congress (in collaboration with 5CC)
Chair- TOXINS - Breakthroughs from IMCAS World Congress (in collaboration with 5CC)
Toxins overview : USA- BEYOND EXOSOMES & PRP - Cellular reboot
New updates on exosomes – in the US and abroad – what’s new and what’s real- CLINICAL DERMATOLOGY - Acne 360°: hormonal, topical, & procedural treatments (in collaboration with AMD)
Acne vulgaris treatments with lasers & EBD’s in 2026- CLINICAL DERMATOLOGY - Scar by scar pt 2 (in collaboration with Keloid Research Foundation)
The use of EBD’s in the treatment of hypertrophic scars and keloids- REGENERATIVE - exosomes, autologus or non autologus; the battle
Exosomes - What's Behind Their Rapid Explosion into Regenerative Medicine?Discover IMCAS Academy
Need assistance?